Journal of Internal Medicine Concepts & Practice >
Relationship between pathological changes under gastroscopy and Helicobacter pylori antibody groups in serum
Received date: 2021-05-17
Online published: 2022-08-08
Objective To investigate the prevalence of serum Helicobacter pylori(Hp) infection in the patients with upper gastrointestinal symptoms and the relationship between Hp antibody groups and pathological changes under gastroscopy. Methods A total of 705 patients including 389 males and 316 females underwent gastroscopy from August 2018 to January 2020 (age between 13 and 88 years). Four Hp antibodies were detected by immunoblotting, and the infection rates of type Ⅰ and type Ⅱ Hp were multiple compared by sex and age groups(every 10 years old, which were≤30, 31~≤40, 41~≤50, 51~≤60, 61~≤70, ≥71 years). Divided into superficial gastritis, superficial gastritis with erosion, esophagitis, chronic atrophic gastritis, gastric ulcer and gastric cancer groups through gastroscopy. The positive rates of HP antibodies detected between groups were compared, and the data of detected antibodies including toxin-related protein cytotoxin-associated protein(CagA), vacuolating cytotoxin gene(VacA) and CagA+VacA were collected and analyzed. Results The total HP infection rate was 60.6%, and the infection rate of Hp type Ⅰ in was higher than that of Hp type Ⅱ. The HP infection rates in male were 59.4% (231) and 62.0% (196) in female, and didn’t show difference (χ2=0.510, P=0.475). Age into 6 groups with Hp infection rate (P<0.05), Hp Ⅰ infection rate within each age group (P<0.05). The gastric cancer group had highest positive rate of Hp Ⅰ(60.0%), while the esophagitis group had highest rate of Hp Ⅱ (17.5%), significant difference between type Ⅰ positive rate (P<0.05). In the cases with positive Hp Ⅰ, the CagA positive rate in gastric cancer was 70.6%, the VacA positive rate in superficial and erosive gastritis was 17.0%, and the positive rate of CagA+VacA in esophagitis was 52.0%. Conclusions Hp infection is a key cause of the most gastric diseases. Hp Ⅰ is currently the most common type of Hp infection in the clinic, which is more pathogenic.
LIU Qinghua, LI Zhen, ZHANG Xiaowei, ZHANG Xinhuan, ZHANG Hong . Relationship between pathological changes under gastroscopy and Helicobacter pylori antibody groups in serum[J]. Journal of Internal Medicine Concepts & Practice, 2022 , 17(04) : 313 -316 . DOI: 10.16138/j.1673-6087.2022.04.008
[1] | 刘文忠. “第五次全国幽门螺杆菌感染处理共识报告”解读[J]. 胃肠病学, 2017, 22(6): 321-324. |
[2] | Sokic-Milutinovic A, Alempijevic T, Milosavljevic T. Role of Helicobacter pylori infection in gastric carcinogenesis: current knowledge and future directions[J]. World J Gastroenterol, 2015, 21(41): 11654-11672. |
[3] | Nell S, Estibariz I, Krebes J, et al. Genome and methylome variation in Helicobacter pylori with a cag pathogenicity Island during early stages of human infection[J]. Gastroenterology, 2018, 154(3): 612-623. |
[4] | 张万岱, 胡伏莲, 萧树东, 等. 中国自然人群幽门螺杆菌感染的流行病学调查[J]. 现代消化及介入诊疗, 2010, 15(5): 265-270. |
[5] | 郭晓婕, 吴江. 幽门螺杆菌抗体检测493例结果分析[J]. 淮海医药, 2018, 36(3): 297-299. |
[6] | Bibi F, Alvi SA, Sawan SA, et al. Detection and genotyping of Helicobacter pylori among gastric ulcer and cancer patients from Saudi Arabia[J]. Pak J Med Sci, 2017, 33(2): 320-324. |
[7] | van der Ende A, Pan ZJ, Bart A, et al. CagA-positive Helicobacter pylori populations in China and the Netherlands are distinct[J]. Infect Immun, 1998, 66(5): 1822-1826. |
[8] | Meng WP, Wang ZQ, Deng JQ, et al. The role of H. pylori CagA in regulating hormones of functional dyspepsia patients[J]. Gastroenterol Res Pract, 2016, 2016: 7150959. |
[9] | Park JY, Forman D, Waskito LA, et al. Epidemiology of Helicobacter pylori and CagA-positive infections and global variations in gastric cancer[J]. Toxins, 2018, 10(4): 163. |
[10] | 朱莲, 汤仁仙, 邵健忠. 幽门螺杆菌临床菌株主要蛋白抗原表达及其诱导宿主产生抗体差异性的研究[J]. 浙江大学学报, 2009, 36(1):90-96. |
[11] | 陈力, 张成栋, 殷洁, 等. 青岛地区胃粘膜病变患者Hp及其相关抗体的分析[J]. 胃肠病学和肝病学杂志, 2017, 26(6): 682-685. |
[12] | 何媛, 赵晶, 林泳. 血清幽门螺杆菌抗体分型与胃部疾病的关系研究[J]. 中国全科医学, 2019, 22(36): 4424-4428. |
[13] | 徐佳升, 王彪, 谢川. 幽门螺杆菌菌株特异性与胃癌关系研究进展[J]. 中国全科医学, 2018, 21(18): 2258-2262. |
[14] | Chmiela M, Kupcinskas J. Review: pathogenesis of Helicobacter pylori infection[J]. Helicobacter, 2019, 24 Suppl 1: e12638. |
[15] | Almeida N, Donato MM, Romãozinho JM, et al. Correlation of Helicobacter pylori genotypes with gastric histopathology in the central region of a South-European country[J]. Dig Dis Sci, 2015, 60(1): 74-85. |
[16] | Hillemann D, Rüsch-Gerdes S, Boehme C, et al. Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF system[J]. J Clin Microbiol, 2011, 49(4): 1202-1205. |
[17] | 韩玉刚, 崔云朋, 李静, 等. 济南地区自然人群幽门螺杆菌感染情况及其免疫分型研究[J]. 检验医学与临床, 2020, 17(5): 630-632. |
[18] | 吴灵敏. 安顺地区幽门螺旋杆菌感染状况分析[J]. 航空航天医学杂志, 2021, 32(1): 46-48. |
[19] | Tonkic A, Vukovic J, Vrebalov Cindro P, et al. Diagnosis of Helicobacter pylori infection[J]. Wien Klin Wochenschr, 2018, 130(17): 530-534. |
[20] | Hu Y, Wan JH, Li XY, et al. Systematic review with meta-analysis: the global recurrence rate of Helicobacter pylori[J]. Aliment pharmacol Ther, 2017, 46(9): 773-779. |
/
〈 |
|
〉 |